The Genome of Canarypox Virus

Journal of Virology

Volumn 78, Issue 1, 2004, Pages 353-366

  Tulman, E R ^a   Afonso, C L ^a   Lu, Z ^a   Zsak, L ^a   Kutish, G F ^a   Rock, D L ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; HELICASE; INTERLEUKIN 10 LIKE PROTEIN; NERVE GROWTH FACTOR BETA SUBUNIT; PIR1 RNA PHOSPHATASE; RIBONUCLEOTIDE REDUCTASE; THIOREDOXIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG; VACCINE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CANARYPOX VIRUS; DRUG DESIGN; FOWLPOX VIRUS; GENE REARRANGEMENT; GENE SEQUENCE; GENE STRUCTURE; GENETIC CODE; GENETIC VARIABILITY; HOST RANGE; INVERTED REPEAT; LONG TERMINAL REPEAT; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS GENOME; VIRUS VIRULENCE;

ANIMALS; CANARYPOX VIRUS; CHICK EMBRYO; CLONING, MOLECULAR; GENOME, VIRAL; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

EID: 0346995104     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.1.353-366.2004     Document Type: Article

References (102)

1. Afonso, C. L., E. R. Tulman, Z. Lu, E. Oma, G. F. Kutish, and D. L. Rock. 1999. The genome of Melanoplus sanguinipes entomopoxvirus. J. Virol. 73:533-552.
2. Afonso, C. L., E. R. Tulman, Z. Lu, L. Zsak, G. F. Kutish, and D. L. Rock. 2000. The genome of fowlpox virus. J. Virol. 74:3815-3831.
3. Aguiar, J. C., R. C. Hedstrom, W. O. Rogers, Y. Charoenvit, J. B. Sacei, Jr., D. E. Lanar, V. F. Majam, R. R. Stout, and S. L. Hoffman. 2001. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 20:275-280.
4. Aloe, L., M. D. Simone, and F. Properzi. 1999. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microsc. Res. Tech. 45:285-291.
5. Amano, H., S. Morikawa, H. Shimizu, I. Shoji, D. Kurosawa, Y. Matsuura, T. Miyamura, and Y. Ueda. 1999. Identification of the canarypox virus thymidine kinase gene and insertion of foreign genes. Virology 256:280-290.
6. Bawden, A. L., K. J. Glassberg, J. Diggans, R. Shaw, W. Farmerie, R. W. Moyer, D. A. Liebermann, and B. Hoffman. 2000. Complete genomic sequence of the Amsacta moorei entomopoxvirus: analysis and comparison with other poxviruses. Virology 274:120-139.
7. Baxevanis, A. D., F. Puehler, H. Schwarz, B. Waidner, J. Kalinowski, B. Kaspers, S. Bereswill, and P. Staeheli. 2003. The molecular biology database collection: 2003 update. Nucleic Acids Res. 31:1-12.
8. Beaudette, F. R. 1953. The identity of canary pox and "Schnappkrankheit" with notes on vaccination and modification of the virus. Proc. U.S. Livestock Sanitary Assoc. 57:249-272.
9. Benson, G. 1999. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 27:573-580.
10. Blaesse, M., T. Kupke, R. Huber, and S. Steinbacher. 2000. Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate. EMBO J. 19:6299-6310.
11. Boulanger, D., P. Green, B. Jones, G. Henriquet, L. G. Hunt, S. M. Laidlaw, P. Monaghan, and M. A. Skinner. 2002. Identification and characterization of three immunodominant structural proteins of fowlpox virus. J. Virol. 76:9844-9855.
12. Boulanger, D., T. Smith, and M. A. Skinner. 2000. Morphogenesis and release of fowlpox virus. J. Gen. Virol. 81:675-687.
13. Brojatsch, J., J. Naughton, H. B. Adkins, and J. A. Young. 2000. TVB receptors for cytopathic and noncytopathic subgroups of avian leukosis viruses are functional death receptors. J. Virol. 74:11490-11494.
14. Brojatsch, J., J. Naughton, M. M. Rolls, K. Zingler, and J. A. Young. 1996. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87:845-855.
15. Burnet, F. M., and J. E. Bernard. 1933. A virus disease of the canary of the fowl-pox group, J. Pathol. Bacteriol. 37:107-122.
16. Cavill, J. P. 1964. Canary pox: report of an outbreak in roller canaries (Serinus canarius). Vet. Rec. 76:463-465.
17. Connor, J. H., D. C. Weiser, S. Li, J. M. Hallenbeck, and S. Shenolikar. 2001. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol. Cell. Biol. 21:6841-6850.
18. Coscoy, L., D. J. Sanchez, and D. Ganem. 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155:1265-1273.
19. Deshpande, T., T. Takagi, L. Hao, S. Buratowski, and H. Charbonneau. 1999. Human PIR1 of the protein-tyrosine phosphatase superfamily has RNA 5′-triphosphatase and diphosphatase activities. J. Biol. Chem. 274: 16590-16594.
20. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
21. Di Pasquale, G., and J. A. Chiorini. 2003. PKA/PrKX activity is a modulator of AAV/adenovirus interaction. EMBO J. 22:1716-1724.
22. Durant, A. J., and H. C. McDougle. 1938. Investigation of pox in canaries. Proc. U.S. Livestock Sanitary Assoc. 42:181-188.
23. Durum, S. K., and J. J. Oppenheim. 1993. Proinflammatory cytokines and immunity, p. 801-835. In W. E. Paul (ed.), Fundamental immunology, 3rd ed. Raven Press, New York, N.Y.
24. + T-cell responses from chronically infected individuals. J. Virol. 75:2142-2153.
25. Everett, R. D., A. Orr, and C. M. Preston. 1998. A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J. 17:7161-7169.
26. Ewing, B., and P. Green. 1998. Base-calling of automated sequencer traces using Phred. II. Error probabilities. Genome Res. 8:186-194.
27. Ewing, B., L. Hillier, M. C. Wendl, and P. Green. 1998. Base-calling of automated sequencer traces using Phred. I. Accuracy assessment. Genome Res. 8:175-185.
28. Fang, Z. Y., K. Limbach, J. Tartaglia, J. Hammonds, X. Chen, and P. Spearman. 2001. Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells. Virology 291:272-284.
29. Fickenscher, H., S. Hor, H. Kupers, A. Knappe, S. Wittmann, H. Sticht, H. Huang, A. Saxena, and J. Xiang. 2002. The interleukin-10 family of cytokines. Trends Immunol. 23:89-96.
30. Galtier, N., M. Gouy, and C. Gautier. 1996. SEAVIEW and PHYLO WIN: two graphic tools for sequence alignment and molecular phylogeny. Comput. Appl. Biol. Sci. 12:543-554.
31. Garaci, E., M. C. Caroleo, L. Aloe, S. Aquaro, M. Piacentini, N. Costa, A. Amendola, A. Micera, R. Calio, C. F. Perno, and R. Levi-Montalcini. 1999. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc. Natl. Acad. Sci. USA 96:14013-14018.
32. Ghildyal, N., W. M. Schnitzlein, and D. N. Tripathy. 1989. Genetic and antigenic differences between fowlpox and quailpox viruses. Arch. Virol. 106:85-92.
33. Giddens, W. E., Jr., L. J. Swango, J. D. Henderson, Jr., R. A. Lewis, D. S. Farner, A. Carlos, and W. C. Dolowy. 1971. Canary pox in sparrows and canaries (Fringillidae) and in weavers (Ploceidae). Pathology and host specificity of the virus. Vet. Pathol. 8:260-280.
34. Gilbert, P. B., Y. L. Chiu, M. Allen, D. N. Lawrence, C. Chapdu, H. Israel, D. Holman, M. C. Keefer, M. Wolff, and S. E. Frey. 2003. Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored phase I and II clinical trials. Vaccine 21:2933-2947.
35. Gonczol, E., and S. Plotkin. 2001. Development of a cytomegalovirus vaccine: lessons from recent clinical trials. Expert Opin. Biol. Ther. 1:401-412.
36. Gordon, D., C. Abajian, and P. Green. 1998. Consed: a graphical tool for sequence finishing. Genome Res. 8:192-202.
37. Hernandez-Acosta, P., D. G. Schmid, G. Jung, F. A. Culianez-Macia, and T. Kupke. 2002. Molecular characterization of the Arabidopsis thaliana flavoprotein AtHAL3a reveals the general reaction mechanism of 4′-phosphopantothenoylcysteine decarboxylases. J. Biol. Chem. 277:20490-20498.
38. Hertig, C., B. E. Coupar, A. R. Gould, and D. B. Boyle. 1997. Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus. Virology 235:367-376.
39. Hitchner, S. B. 1981. Canary pox vaccination with live embryo-attenuated virus. Avian Dis. 25:874-881.
40. Huang, X., and A. Madan. 1999. CAP3: a DNA sequence assembly program. Genome Res. 9:868-877.
41. Ignatius, R., M. Marovich, E. Mehlhop, L. Villamide, K. Mahnke, W. I. Cox, F. Isdell, S. S. Frankel, J. R. Mascola, R. M. Steinman, and M. Pope. 2000. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion. J. Virol. 74:11329-11338.
42. Imlach, W., C. A. McCaughan, A. A. Mercer, D. Haig, and S. B. Fleming. 2002. Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages. J. Gen. Virol. 83:1049-1058.
43. Iyer, L. M., E. V. Koonin, and L. Aravind. 2002. Extensive domain shuffling in transcription regulators of DNA viruses and implications for the origin of fungal APSES transcription factors. Genome Biol. 3:0012. [Online.] http:// genomebiology.com/2002/3/3/research/0012.
44. Jin, X., M. Ramanathan, Jr., S. Barsoum, G. R. Deschenes, L. Ba, J. Binley, D. Schiller, D. E. Bauer, D. C. Chen, A. Hurley, L. Gebuhrer, R. El Habib, P. Caudrelier, M. Klein, L. Zhang, D. D. Ho, and M. Markowitz. 2002. Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy. J. Virol. 76:2206-2216.
45. Johnson, B. J., and A. E. Castro. 1986. Canary pox causing high mortality in an aviary. J. Am. Vet. Med. Assoc. 189:1345-1347.
46. Junn, E., S. H. Han, J. Y. Im, Y. Yang, E. W. Cho, H. D. Um, D. K. Kim, K. W. Lee, P. L. Han, S. G. Rhee, and I. Choi. 2000. Vitamin D3 upregulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 164:6287-6295.
47. Kawakita, M., G. S. Rao, J. K. Ritchey, D. K. Ornstein, M. A. Hudson, J. Tartaglia, E. Paoletti, P. A. Humphrey, T. J. Harmon, and T. L. Ratliff. 1997. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth. J. Natl. Cancer Inst. 89:428-436.
48. Kim, T. J., and D. N. Tripathy. 2001. Reticuloendotheliosis virus integration in the fowl poxvirus genome: not a recent event. Avian Dis. 45:663-669.
49. Kong, L. J., B. M. Orozco, J. L. Roe, S. Nagar, S. Ou, H. S. Feiler, T. Durfee, A. B. Miller, W. Gruissem, D. Robertson, and L. Hanley-Bowdoin. 2000. A geminivirus replication protein interacts with the retinoblastoma protein through a novel domain to determine symptoms and tissue specificity of infection in plants. EMBO J. 19:3485-3495.
50. Koonin, E. V., and T. V. Ilyina. 1993. Computer-assisted dissection of rolling circle DNA replication. Biosystems 30:241-268.
51. Laidlaw, S. M., M. A. Anwar, W. Thomas, P. Green, K. Shaw, and M. A. Skinner. 1998. Fowlpox virus encodes nonessential homologs of cellular α-SNAP, PC-1, and an orphan human homolog of a secreted nematode protein. J. Virol. 72:6742-6751.
52. Li, Y., and L. K. Miller. 1995. Properties of a baculovirus mutant defective in the protein phosphatase gene. J. Virol. 69:4533-4537.
53. Liebermann, D. A., and B. Hoffman. 2002. Myeloid differentiation (MyD)/ growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia 16:527-541.
54. Luque, A., A. P. Sanz-Burgos, E. Ramirez-Parra, M. M. Castellano, and C. Gutierrez. 2002. Interaction of geminivirus Rep protein with replication factor C and its potential role during geminivirus DNA replication. Virology 302:83-94.
55. Marovich, M. A., J. R. Mascola, M. A. Eller, M. K. Louder, P. A. Caudrelier, R. El-Habib, S. Ratto-Kim, J. H. Cox, J. R. Currier, B. L. Levine, C. H. June, W. B. Bernstein, M. L. Robb, B. Schuler-Thurner, R. M. Steinman, D. L. Birx, and S. Schlesinger-Frankel. 2002. Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells. J. Infect. Dis. 186:1242-1252.
56. Massague, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753-791.
57. Moss, B. 2001. Poxviridae: the viruses and their replication, p. 2849-2883. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott, Williams and Wilkins, Philadelphia, Pa.
58. Mossman, K. L., and J. R. Smiley. 2002. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76:1995-1998.
59. Motta, I., F. Andre, A. Lim, J. Tartaglia, W. I. Cox, L. Zitvogel, E. Angevin, and P. Kourilsky. 2001. Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells. J. Immunol. 167:1795-1802.
60. Moyer, R. W., B. Arif, D. N. Black, D. B. Boyle, R. M. Buller, K. R. Dumbell, J. J. Esposito, G. McFadden, B. Moss, A. A. Mercer, S. Ropp, D. N. Tripathy, and C. Upton. 2000. Family Poxviridae. In M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle, and R. B. Wickner (ed.), Virus taxonomy. Academic Press, New York, N.Y.
61. Nishinaka, Y., H. Masutani, H. Nakamura, and J. Yodoi. 2001. Regulatory roles of thioredoxin in oxidative stress-induced cellular responses. Redox Rep. 6:289-295.
62. 3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 274:21645-21650.
63. Novick, D., S. H. Kim, G. Fantuzzi, L. L. Reznikov, C. A. Dinarello, and M. Rubinstein. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10:127-136.
64. Oh, C. S., D. A. Toke, S. Mandala, and C. E. Martin. 1997. ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J. Biol. Chem. 272:17376-17384.
65. Orozco, B. M., and L. Hanley-Bowdoin. 1998. Conserved sequence and structural motifs contribute to the DNA binding and cleavage activities of a geminivirus replication protein. J. Biol. Chem. 273:24448-24456.
66. Orozco, B. M., L. J. Kong, L. A. Batts, S. Elledge, and L. Hanley-Bowdoin. 2000. The multifunctional character of a geminivirus replication protein is reflected by its complex oligomerization properties. J. Biol. Chem. 275:6114-6122.
67. Pancholi, P., D. H. Lee, Q. Liu, C. Tackney, P. Taylor, M. Perkus, L. Andrus, B. Brotman, and A. M. Prince. 2001. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology 33:448-454.
68. Pancholi, P., Q. Liu, N. Tricoche, P. Zhang, M. E. Perkus, and A. M. Prince. 2000. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins. J. Infect. Dis. 182:18-27.
69. Paoletti, E. 1996. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA 93:11349-11353.
70. Pearson, W. R., and D. J. Lipman. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA 85:2444-2448.
71. Pearson, W. R., T. Wood, Z. Zhang, and W. Miller. 1997. Comparison of DNA sequences with protein sequences. Genomics 46:24-36.
72. Perkus, M. E., S. J. Goebel, S. W. Davis, G. P. Johnson, K. Limbach, E. K. Norton, and E. Paoletti. 1990. Vaccinia virus host range genes. Virology 179:276-286.
73. Pica, F., A. Volpi, A. Serafino, M. Fraschetti, O. Franzese, and E. Garaci. 2000. Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells. Blood 95:2905-2912.
74. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:503-533.
75. Pickart, C. M. 2001. Ubiquitin enters the new millennium. Mol. Cell 8:499-504.
76. Puehler, F., H. Schwarz, B. Waidner, J. Kalinowski, B. Kaspers, S. Bereswill, and P. Staeheli. 2003. An interferon-gamma-binding protein of novel structure encoded by the fowlpox virus. J. Biol. Chem. 278:6905-6911.
77. Sadasiv, E. C., P. W. Chang, and G. Gulka. 1985. Morphogenesis of canary poxvirus and its entrance into inclusion bodies. Am. J. Vet. Res. 46:529-535.
78. 2+ influx-mediated suppression of vitamin D3 up-regulated protein 1 (VDUP1) mRNA in cerebellar granule neurons undergoing apoptosis. J. Neurochem. 78:1267-1276.
79. Schnitzlein, W. M., N. Ghildyal, and D. N. Tripathy. 1988. Genomic and antigenic characterization of avipoxviruses. Virus Res. 10:65-75.
80. Schwartz, S., Z. Zhang, K. A. Frazer, A. Smit, C. Riemer, J. Bouck, R. Gibbs, R. Hardison, and W. Miller. 2000. PipMaker-a web server for aligning two genomic DNA sequences. Genome Res. 10:577-586.
81. Senkevich, T. G., E. V. Koonin, J. J. Bugert, G. Darai, and B. Moss. 1997. The genome of Molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology 233:19-42.
82. Senkevich, T. G., E. V. Koonin, and R. M. L. Buller. 1994. A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. Virology 198:118-128.
83. Sofroniew, M. V., C. L. Howe, and W. C. Mobley. 2001. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24:1217-1281.
84. Somogyi, P., J. Frazier, and M. A. Skinner. 1993. Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells. Virology 197:439-444.
85. Spencer, J. V., K. M. Lockridge, P. A. Barry, G. Lin, M. Tsang, M. E. Penfold, and T. J. Schall. 2002. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76:1285-1292.
86. Srinivasan, V., W. M. Schnitzlein, and D. N. Tripathy. 2001. Fowlpox virus encodes a novel DNA repair enzyme, CPD-photolyase, that restores infectivity of UV light-damaged virus. J. Virol. 75:1681-1688.
87. Staeheli, P., F. Puehler, K. Schneider, T. W. Gobel, and B. Kaspers. 2001. Cytokines of birds: conserved functions-a largely different look. J. Interferon Cytokine Res. 21:993-1010.
88. Strack, B., A. Calistri, M. A. Accola, G. Palu, H. G. Gottlinger, R. E. Means, S. Ishido, X. Alvarez, and J. U. Jung. 2000. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. USA 97:13063-13068.
89. Takagi, T., G. S. Taylor, T. Kusakabe, H. Charbonneau, and S. Buratowski. 1998. A protein tyrosine phosphatase-like protein from baculovirus has RNA 5′-triphosphatase and diphosphatase activities. Proc. Natl. Acad. Sci. USA 95:9808-9812.
90. Tartaglia, J., M. C. Bonnet, N. Berinstein, B. Barber, M. Klein, and P. Moingeon. 2001. Therapeutic vaccines against melanoma and colorectal cancer. Vaccine 19:2571-2575.
91. Tartaglia, J., M. E. Perkus, J. Taylor, E. K. Norton, J. C. Audonnet, W. I. Cox, S. W. Davis, J. van der Hoeven, B. Meignier, M. Riviere, B. Languet, and E. Paoletti. 1992. NYVAC: a highly attenuated strain of vaccinia virus. Virology 188:217-232.
92. Taylor, J., B. Meignier, J. Tartaglia, B. Languet, J. VanderHoeven, G. Franchini, C. Trimarchi, and E. Paoletti. 1995. Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine 13:539-549.
93. Taylor, J., and E. Paoletti. 1988. Fowlpox virus as a vector in non-avian species. Vaccine 6:466-468.
94. Taylor, J., C. Trimarchi, R. Weinberg, B. Languet, F. Guillemin, P. Desmettre, and E. Paoletti. 1991. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 9:190-193.
95. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
96. Thomson, B. J., S. Efstathiou, and R. W. Honess. 1991. Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6. Nature 351:78-80.
97. Tripathy, D. N., and W. M. Reed. 1997. Pox, p. 643-659. In B. W. Calnek, H. J. Barnes, C. W. Beard, L. R. McDougald, and Y. M. Saif (ed.), Diseases of poultry, 10th ed. Iowa State University Press, Ames, Iowa.
98. Tripathy, D. N., W. M. Schnitzlein, P. J. Morris, D. L. Janssen, J. K. Zuba, G. Massey, and C. T. Atkinson.1 2000. Characterization of poxviruses from forest birds in Hawaii. J. Wildl. Dis. 36:225-230.
99. Villoslada, P., S. L. Hauser, I. Bartke, J. Unger, N. Heald, D. Rosenberg, S. W. Cheung, W. C. Mobley, S. Fisher, and C. P. Genain. 2000. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med. 191:1799-1806.
100. Vink, C., E. Beuken, and C. A. Bruggeman. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:7656-7665.
101. Xiang, Y., and B. Moss. 2001. Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J. Virol. 75:9947-9954.
102. Yuan, Y., D. M. Li, and H. Sun. 1998. PIR1, a novel phosphatase that exhibits high affinity to RNA · ribonucleoprotein complexes. J. Biol. Chem. 273:20347-20353.